| Name: | Fulvestrant EP Impurity C |
| Catalogue No. | VL234003 |
| CAS No. | N/A |
| Molecular Formula | C41H65F5O4S2 |
| Molecular Weight | 781.07 |
| Status | In-stock |
| IUPAC Name | 7-[9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol |
| Synonyms | Fulvestrant Extended |
| Appearance | Off White Powder |
| Description | Fulvestrant EP Impurity C or 7-[9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol is an impurity of Fulvestrant. Fulvestrant is used to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women |
| References | “Sci-Hub | Fulvestrant: An Oestrogen Receptor Antagonist with a Novel Mechanism of Action | 10.1038/Sj.bjc.6601629.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1038/sj.bjc.6601629. |
![7β-Acetyloxy-7α-[9-(dimethyl(tert-butylsilyloxy)nonyl]estr-4-en-3-one](/public/site/files/site_images/thumb_7beta-acetyloxy-7alpha-9-dimethyl-tert-butylsilyloxy-nonyl-estr-4-en-3-one17932.png)
![Fulvestrant 9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonanol](/public/site/files/site_images/thumb_fulvestrant-944555pentafluoropentylthiononanol35935.PNG)
![Fulvestrant 9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonyl Bromide](/public/site/files/site_images/thumb_fulvestrant-9944555pentafluoropentylsulfenylnonylsulfenylnonyl-bromide21235.PNG)
